A carregar...
Gene Therapy for Immune Tolerance Induction in Hemophilia with Inhibitors
The development of inhibitors, neutralizing alloantibodies to Factor VIII (FVIII) or Factor IX (FIX), is the most significant complication of protein replacement therapy for patients with hemophilia and is associated with increased mortality as well as substantial physical, psychosocial, and financi...
Na minha lista:
| Publicado no: | J Thromb Haemost |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907803/ https://ncbi.nlm.nih.gov/pubmed/27061380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13331 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|